Z
Zhenmei Li
Researcher at St. Jude Children's Research Hospital
Publications - 18
Citations - 871
Zhenmei Li is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Cancer & Dihydropteroate synthase. The author has an hindex of 10, co-authored 16 publications receiving 724 citations.
Papers
More filters
Journal ArticleDOI
Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism.
Allen C. Price,Keum-Hwa Choi,Richard J. Heath,Zhenmei Li,Stephen W. White,Charles O. Rock,Charles O. Rock +6 more
TL;DR: FabB[H333N] was significantly more resistant to both antibiotics than FabB and had an affinity for TLM an order of magnitude less than the wild-type enzyme, illustrating that the two-histidine active site architecture is critical to protein-antibiotic interaction.
Journal ArticleDOI
Catalysis and sulfa drug resistance in dihydropteroate synthase.
Mi Kyung Yun,Yinan Wu,Yinan Wu,Zhenmei Li,Ying Zhao,M. Brett Waddell,Antonio M. Ferreira,Richard E. Lee,Donald Bashford,Donald Bashford,Stephen W. White,Stephen W. White +11 more
TL;DR: Structures of a target enzyme in the bacteria that cause anthrax and bubonic plague may lead to effective drugs, and structural, computational, and mutagenesis studies on the catalytic and resistance mechanisms of DHPS are reported.
Journal ArticleDOI
The FadR.DNA complex. Transcriptional control of fatty acid metabolism in Escherichia coli.
TL;DR: It is suggested that the binding of acyl-CoA disrupts a buried network of charged and polar residues in the C-terminal domain, and the resulting conformational change is transmitted to the N-terminAL domain via a domain-spanning α-helix.
Journal ArticleDOI
Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.
Min-Suk Song,Gyanendra Kumar,William R. Shadrick,Wei Zhou,Trushar Jeevan,Zhenmei Li,P. Jake Slavish,Thomas P. Fabrizio,Sun-Woo Yoon,Thomas R. Webb,Richard J. Webby,Stephen W. White +11 more
TL;DR: Using a prototypical endonuclease inhibitor (L-742,001), mutagenesis was used to select for replication competent resistant mutants and studied the structural and functional basis for the observed resistance, confirming that the end onuclease domain is an excellent drug target for treating influenza.
Journal ArticleDOI
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox
Jun J. Yang,Sandra Milasta,Dongli Hu,Alaa Altahan,Rodrigo B. Interiano,Junfang Zhou,Jesse T. Davidson,Jonathan Low,Wenwei Lin,Ju Bao,Pollyanna Goh,Amit C. Nathwani,Ruoning Wang,Yingdi Wang,Su Sien Ong,Vincent A. Boyd,Brandon Young,Sourav Das,Anang A. Shelat,Yinan Wu,Zhenmei Li,Jie Zheng,Ashutosh Mishra,Yong Cheng,Chunxu Qu,Junmin Peng,Douglas R. Green,Stephen W. White,R. Kiplin Guy,Taosheng Chen,Andrew M. Davidoff +30 more
TL;DR: It is shown that multiple histone dem methylases influence the viability and poor prognosis of neuroblastoma cells, where MYC is often overexpressed, and the approved small-molecule antifungal agent ciclopirox is identified as a novel pan-histone demethylase inhibitor.